Delivery Order SPE2DB20D9354-SPE2DB24FX7G0
Award Date
10/26/23
Potential Completion Date
10/27/23
Potential Value
$22K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at $43,774.08 by the Defense Logistics Agency to supply 60 Jakafi 10 mg tablets. The order is being issued against DMS Pharmaceutical Group's existing indefinite delivery contract with the Defense Logistics Agency to provide pharmaceuticals and medical supplies with a potential value of up to $5 million through December 2025. As a woman-owned small business and pharmaceutical wholesaler, DMS Pharmaceutical...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order for $10,940.31 under an indefinite delivery contract with the Defense Logistics Agency to supply 60 Jakafi 20 mg tablets. The delivery order has a completion date of November 1, 2023 and was awarded on October 31, 2023. DMS Pharmaceutical Group holds this pharmaceutical prime vendor contract with the Defense Logistics Agency to directly supply prescription medications and services to support the operation of...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at thirty-two thousand eight hundred seventeen dollars and eighty-two cents ($32,817.82) by the Defense Logistics Agency to supply sixty (60) 15 mg Jakafi tablets. The delivery order was issued against DMS Pharmaceutical Group's indefinite delivery contract with the Defense Logistics Agency to provide pharmaceuticals and medical supplies with a potential value of up to five million dollars ($5,000,000)...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at $43,789.36 by the Defense Logistics Agency to supply 60 Jakafi 5 mg tablets. The order is being issued against DMS Pharmaceutical Group's existing indefinite delivery contract with the Defense Logistics Agency to provide pharmaceuticals and medical supplies with a total potential value of up to $5 million through December 2025. As a woman-owned small business and pharmaceutical wholesaler, DMS...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order for $22,040.98 under the Defense Logistics Agency Troop Support Medical indefinite delivery contract to provide Jakafi 25 mg tablets. The delivery order requires 60 tablets to be delivered to a facility in Park Ridge, Illinois by May 23, 2023. DMS Pharmaceutical Group holds this pharmaceutical prime vendor contract with the Defense Logistics Agency to directly supply prescription medications and services in...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order against the Defense Logistics Agency Troop Support Medical pharmaceutical prime vendor contract to supply Jakafi 10 mg tablets in the amount of sixty tablets. The order has a potential value of thirty-two thousand eight hundred thirty dollars and fifty-six cents ($32,830.56) and requires completion by December 18, 2023. DMS Pharmaceutical Group will deliver the pharmaceutical products to the place of performance...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at eleven thousand twenty dollars and forty-nine cents ($11,020.49) by the Defense Logistics Agency. This order was issued against DMS Pharmaceutical Group's existing indefinite delivery contract to supply pharmaceutical items and medical products to support military treatment facilities worldwide. Under this particular order, DMS Pharmaceutical Group will provide sixty tablets of Jakafi, a medication used to...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at ten thousand nine hundred forty-seven dollars and thirty-four cents ($10,947.34) by the Defense Logistics Agency to supply sixty (60) tablets of Jakafi 5 mg for use by military treatment facilities. The contract has no set-aside designation and requires delivery by December 12, 2023. DMS Pharmaceutical Group will perform under this delivery order issued against their indefinite delivery contract with the...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at $21,874.32 to supply 60 tablets of Jakafi 15 mg to the Defense Logistics Agency under the agency's pharmaceutical prime vendor contract. As a woman-owned small business, DMS Pharmaceutical Group will provide the specified pharmaceutical item to DLA Troop Support Medical facilities. The delivery order was awarded on November 1, 2023 and has a completion date of November 2, 2023. Additionally, DMS...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order for $10,937.15 under an indefinite delivery contract with the Defense Logistics Agency. The delivery order is for 60 tablets of Jakafi 15 mg to support medical treatment facilities operated by the Defense Logistics Agency. DMS Pharmaceutical Group will provide the pharmaceutical products from their location in Park Ridge, Illinois, with delivery required by December 12, 2023. As a woman-owned small business, DMS...